Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy
about
Approved Antiviral Drugs over the Past 50 YearsProgressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective.Natalizumab treatment of multiple sclerosis: new insights.Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.ViroFind: A novel target-enrichment deep-sequencing platform reveals a complex JC virus population in the brain of PML patients.Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.The Structure of an Infectious Human Polyomavirus and Its Interactions with Cellular Receptors.Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.CD4 T cells control development and maintenance of brain-resident CD8 T cells during polyomavirus infectionBenchmarking Tree and Ancestral Sequence Inference for B Cell Receptor Sequences
P2860
Q27755387-052FCAE6-5F59-40BC-AC09-7E745ADE08BDQ30245002-ABA10D24-FCBA-4999-9054-DC1A5119AEE9Q36878949-8F258C94-0264-4343-9713-82711FE7EBEDQ38801394-2574C519-03E7-4F08-9DA8-0C5B13BEBA9DQ39046213-4C029CD7-A9CF-4773-BB56-38C36F938DB1Q39048568-95696BB5-01FF-4312-94EB-C1A514AC1242Q40761630-B9498CFD-E35A-4BB3-BC4A-D8DEABEBA87BQ40792696-C654B868-5BE2-44F9-9997-9831769CB8A3Q41921811-378A01A5-9AD2-409B-9C46-EEE40408C07FQ47147327-E38C8329-E345-482F-BFB4-E53BF15FA2F5Q47549901-112268CE-4863-43F8-9D52-79847F371149Q49884884-295F3496-7F7A-46D0-9C99-4E2C6E74D2C7Q52801537-6A669875-807C-43C9-82A7-4053BAE4C66DQ54215480-0585807D-52FC-48AC-A32D-997E05865D0BQ58106789-F879B796-471D-4826-A7A7-259887823047Q59133570-A621841F-EB93-47C2-ABEB-E8D88B94A656
P2860
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Broadly neutralizing human mon ...... multifocal leukoencephalopathy
@ast
Broadly neutralizing human mon ...... multifocal leukoencephalopathy
@en
type
label
Broadly neutralizing human mon ...... multifocal leukoencephalopathy
@ast
Broadly neutralizing human mon ...... multifocal leukoencephalopathy
@en
prefLabel
Broadly neutralizing human mon ...... multifocal leukoencephalopathy
@ast
Broadly neutralizing human mon ...... multifocal leukoencephalopathy
@en
P2093
P2860
P50
P1476
Broadly neutralizing human mon ...... multifocal leukoencephalopathy
@en
P2093
Benoit Combaluzier
Brenda J Reinhart
Ilijas Jelcic
Ivan Jelcic
Luisa Ströh
Luzia Senn
Roger M Nitsch
Thilo Stehle
P2860
P304
P356
10.1126/SCITRANSLMED.AAC8691
P407
P577
2015-09-23T00:00:00Z